AN EMERGING GROWTH INDUSTRY
Ackrell Capital is committed to serving the participants of the regulated cannabis industry by providing M&A advisory, private placement and corporate development services. The U.S. Controlled Substances Act prohibits manufacturing, distributing, dispensing or possessing cannabis and its extracts.
To contact a member of the Ackrell Capital Cannabis Investment Banking Team:
Head of Cannabis Investment Banking
ACKRELL CAPITAL CANNABIS INVESTMENT REPORT 2017
Ackrell Capital will be releasing its annual "U.S. Cannabis Investment Report 2017" in December. To be included in its distribution, please subscribe using the form below.